Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management

NCT07464808 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolic Event

Interventions

OTHER: follow up venous thrombo embolic events with routine clexan dose modification guided by anti factor 10 assay
OTHER: follow up venous thromboembolic events with no routine clexan dosage modification and no usage of anti factor 10 assay

Sponsor

Ain Shams University